The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing post–chimeric antigen receptor (CAR) T cell monitoring: Evidence across lisocabtagene maraleucel (liso-cel) pivotal clinical trials and real-world experience.
 
Manali Kamdar
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech
Research Funding - Novartis
Other Relationship - Celgene; Genentech
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Sairah Ahmed
Honoraria - ADC Therapeutics; Genmab; Kite/Gilead
Consulting or Advisory Role - Kite/Gilead; Myeloid Therapeutics
Research Funding - Caribou Biosciences (Inst); Chimagen Biosciences (Inst); Genmab/Seattle Genetics (Inst); Janssen Oncology (Inst); Merck (Inst); Nektar (Inst)
 
Jeremy Abramson
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen; Kite, a Gilead company; Regeneron
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Alimera Sciences; AstraZeneca; BeiGene; Bluebird Bio; Bristol-Myers Squibb; C4 Therapeutics; Caribou Biosciences; Celgene; Cellectar; Century Therapeutics; EMD Serono; Epizyme; Foresight Diagnostics; Genmab; Incyte; Interius Biotherapeutics; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Kymera; Lilly; MorphoSys; MorphoSys; MustangBio; Novartis; Ono Pharmaceutical; Roche/Genentech; Seagen; Takeda
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Cellectis (Inst); Merck (Inst); MustangBio (Inst); Regeneron (Inst); Seagen (Inst)
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune; Omeros; Orca Bio
Consulting or Advisory Role - Adicet Bio; Allogene Therapeutics; AlloVir; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cidara Therapeutics; Equillium; Exivir; Incyte; Kite/Gilead; Medigene; Merck; Nektar; NexImmune; Novartis; Omeros; Sanofi; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
Nausheen Ahmed
Consulting or Advisory Role - BMS; Invivyd; Kite/ Gilead; Legend Biotech
Research Funding - Kite/Gilead (Inst)
 
Sayeef Mirza
Honoraria - Gilead Sciences
Consulting or Advisory Role - Guidepoint Inc
Speakers' Bureau - Bristol-Myers squibb
 
Iris Isufi
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Genmab; Incyte; Janssen
Speakers' Bureau - Kite, a Gilead company
 
Matthew Frigault
Stock and Other Ownership Interests - Immunofree
Consulting or Advisory Role - Bristol-Myers Squibb/Juno; Cytoagents; Gilead Sciences; Novartis
Research Funding - SOBI
Patents, Royalties, Other Intellectual Property - Own IP related to chimeric antigen receptors and T cell manufacturing
 
Jennifer Crombie
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Genentech/Roche; Genmab; Regeneron; Seagen
Research Funding - Abbvie (Inst); Bayer Health (Inst)
 
David Miklos
Honoraria - fosun Kite Biotechnology
Consulting or Advisory Role - Adaptive Biotechnologies; Adicet Bio; Allogene Therapeutics; Caribou Biosciences; Kite, a Gilead company; Miltenyi Biotec; Novartis
Research Funding - 2seventy bio; Adaptive Biotechnologies; Adicet Bio; Alimera Sciences; Kite, a Gilead company; Miltenyi Biotec
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
Travel, Accommodations, Expenses - Kite/Gilead; Kyverna Therapeutics
 
Alberto Vasconcelos
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alessandro Crotta
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Bernasconi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Debasmita Roy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Eric Bleickardt
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Marcelo Pasquini
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Medigene (Inst); Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Kite/Gilead (Inst); Novartis (Inst)
 
Bradley Hunter
Stock and Other Ownership Interests - Actinium Pharmaceuticals
Honoraria - Curio Science
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Astellas Pharma; Bristol-Myers Squibb/Celgene/Juno; Genentech/Roche; Genmab; In8 Bio; Janssen; Kite, a Gilead company; Notable Labs; Novartis; Regeneron
Speakers' Bureau - AbbVie/Genmab; Kite, a Gilead company
Travel, Accommodations, Expenses - AbbVie/Genmab; Bristol Myers Squibb Foundation; Genentech; Genentech; Janssen; Kite, a Gilead company; Novartis; Regeneron
 
Matthew Lunning
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; EUSA Pharma; Fate Therapeutics; Genentech; Genmab; Ipsen; Kite, a Gilead company; Loxo; Novartis; Nurix; Pharmacyclics; Regeneron; Seagen; Takeda
Research Funding - Celgene (Inst); curis (Inst)